# Crexendo, Inc.: overview CXDO · Nasdaq · CIK 1075736 · [Communication](/sectors/communication.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/cxdo.md) · [Financials](/companies/cxdo/financials.md) · [Filings](/companies/cxdo/filings.md) · [Insiders](/companies/cxdo/insiders.md) Latest reported revenue: [$24.6m](/filings/0001654954-26-007265.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 4, 2026 (XBRL us-gaap:Revenues, accession 0001654954-26-007265). ## Last eight quarters | Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [15.6](/filings/0001654954-25-012585.md) | [16.2](/filings/0001654954-26-001848.md) | [16.1](/filings/0001654954-26-004365.md) | [16.6](/filings/0001654954-26-007265.md) | [17.5](/filings/0001654954-25-012585.md) | [18.1](/filings/0001654954-26-001848.md) | [20.7](/filings/0001654954-26-004365.md) | [24.6](/filings/0001654954-26-007265.md) | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | [0.9%](/filings/0001654954-26-001848.md) | [3.9%](/filings/0001654954-26-001848.md) | [7.2%](/filings/0001654954-26-004365.md) | [6.7%](/filings/0001654954-26-007265.md) | [7.5%](/filings/0001654954-26-001848.md) | [6.3%](/filings/0001654954-26-001848.md) | [2.1%](/filings/0001654954-26-004365.md) | [4.3%](/filings/0001654954-26-007265.md) | | Net margin | % | [0.9%](/filings/0001654954-26-001848.md) | [3.1%](/filings/0001654954-26-001848.md) | [7.3%](/filings/0001654954-26-007265.md) | [7.4%](/filings/0001654954-26-007265.md) | [8.3%](/filings/0001654954-26-001848.md) | [6.7%](/filings/0001654954-26-001848.md) | [2.8%](/filings/0001654954-26-007265.md) | [4.3%](/filings/0001654954-26-007265.md) | | Diluted EPS | $ per share | [0.00](/filings/0001654954-26-001848.md) | [0.02](/filings/0001654954-26-001848.md) | [0.04](/filings/0001654954-26-004365.md) | [0.04](/filings/0001654954-26-007265.md) | [0.05](/filings/0001654954-26-001848.md) | [0.04](/filings/0001654954-26-001848.md) | [0.02](/filings/0001654954-26-004365.md) | [0.03](/filings/0001654954-26-007265.md) | | Free cash flow | $m | [1.6 d](/filings/0001654954-25-012585.md) | [2.2 d](/filings/0001654954-26-001848.md) | [1.2](/filings/0001654954-26-004365.md) | [1.3 d](/filings/0001654954-26-007265.md) | [4.4 d](/filings/0001654954-25-012585.md) | [2.3 d](/filings/0001654954-26-001848.md) | not reported | not reported | - Revenue. XBRL Revenue: us-gaap:Revenues; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. - Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure. ## Last five fiscal years | Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [28.1](/filings/0001654954-23-002860.md) | [37.6](/filings/0001654954-24-002655.md) | [53.2](/filings/0001654954-25-002287.md) | [60.8](/filings/0001654954-26-001848.md) | [68.2](/filings/0001654954-26-001848.md) | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | [(10.0%)](/filings/0001654954-23-002860.md) | [(99.6%)](/filings/0001654954-24-002655.md) | [(3.2%)](/filings/0001654954-25-002287.md) | [3.0%](/filings/0001654954-26-001848.md) | [6.9%](/filings/0001654954-26-001848.md) | | Net margin | % | [(8.7%)](/filings/0001654954-23-002860.md) | [(94.3%)](/filings/0001654954-24-002655.md) | [(0.7%)](/filings/0001654954-25-002287.md) | [2.8%](/filings/0001654954-26-001848.md) | [7.4%](/filings/0001654954-26-001848.md) | | Diluted EPS | $ per share | [(0.12)](/filings/0001654954-23-002860.md) | [(1.54)](/filings/0001654954-24-002655.md) | [(0.01)](/filings/0001654954-25-002287.md) | [0.06](/filings/0001654954-26-001848.md) | [0.16](/filings/0001654954-26-001848.md) | | Free cash flow | $m | [(1.1)](/filings/0001654954-23-002860.md) | [(0.7)](/filings/0001654954-24-002655.md) | [3.4](/filings/0001654954-25-002287.md) | [6.3](/filings/0001654954-26-001848.md) | [9.3](/filings/0001654954-26-001848.md) | - Revenue. XBRL Revenue: us-gaap:Revenues. - Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/cxdo/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $8.0m | 1,065,200 | | Added +205,905 | | [ROYCE & ASSOCIATES LP](/funds/906304.md) | 2026-06-30 | $7.6m | 1,020,452 | | Added +323,390 | | [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $6.1m | 817,100 | | Added +72,058 | | [ESSEX INVESTMENT MANAGEMENT CO LLC](/funds/201772.md) | 2026-06-30 | $5.3m | 710,874 | | Reduced −32,112 | | [GOLDMAN SACHS GROUP INC](/funds/886982.md) | 2026-06-30 | $3.7m | 491,747 | | Added +404,911 | | [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $3.4m | 461,170 | | Added +16,830 | | [RENAISSANCE TECHNOLOGIES LLC](/funds/1037389.md) | 2026-06-30 | $3.4m | 450,981 | | Added +104,244 | | [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $3.3m | 444,639 | | Added +64,312 | | [Qube Research & Technologies Ltd](/funds/1729829.md) | 2026-06-30 | $3.2m | 424,362 | | Added +354,467 | | [ARROWSTREET CAPITAL, LIMITED PARTNERSHIP](/funds/1164508.md) | 2026-06-30 | $3.1m | 410,602 | | Added +4,160 | ## Recent filings [All 1,564 filings](/companies/cxdo/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-10-19 | 16:15 ET | [DEF 14A](/filings/0001654954-26-009040.md) | Proxy statement, period 2026-10-19 | 0001654954-26-009040 | | 2026-10-13 | 09:30 ET | [8-K](/filings/0001654954-26-008916.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001654954-26-008916 | | 2026-08-10 | 17:10 ET | [8-K](/filings/0001654954-26-007432.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001654954-26-007432 | | 2026-08-04 | 17:16 ET | [10-Q](/filings/0001654954-26-007265.md) | Quarterly report, period 2026-06-30 | 0001654954-26-007265 | | 2026-08-04 | 16:00 ET | [8-K](/filings/0001654954-26-007262.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001654954-26-007262 | | 2026-07-30 | 16:30 ET | [8-K](/filings/0001654954-26-007033.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001654954-26-007033 | | 2026-05-12 | 16:36 ET | [8-K](/filings/0001654954-26-004739.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001654954-26-004739 | | 2026-05-05 | 17:17 ET | [8-K](/filings/0001654954-26-004366.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001654954-26-004366 | | 2026-05-05 | 17:16 ET | [10-Q](/filings/0001654954-26-004365.md) | Quarterly report, period 2026-03-31 | 0001654954-26-004365 | | 2026-05-05 | 16:00 ET | [8-K](/filings/0001654954-26-004361.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001654954-26-004361 | ## Latest annual report [Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001654954-26-001848.md), filed Mar 3, 2026. ## Forecast league Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/da663c25-8353-496a-91e3-470842d67f85) ## About the filer - CIK: 1075736 - Tickers: CXDO - Exchange: Nasdaq - SIC code: 4813 Telephone Communications (No Radiotelephone) - State of incorporation: DE - Filer category: Non-accelerated filer
Smaller reporting company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 27, 2026, 20:43 ET. No prices; not investment advice.